Tag: nasdaq:tenx

December 5, 2019

5 Top Pharmaceutical News Stories of 2019

What pharmaceutical news stories caught investors' attention in 2019? We run through our five most popular articles.
October 31, 2019

Tenax Therapeutics Updates on Phase 2 Pulmonary Trial

The company said that 15 patients have been randomized and that there have been no serious adverse events reported yet.
January 30, 2019

Video Round-Up: Biotech Showcase Conference 2019

The Biotech Showcase this year took place in San Francisco and gave international and local guests an opportunity to meet.
January 22, 2019

Tenax Therapeutics Working on Phase 2 Trial

Anthony DiTonno, CEO of Tenax Therapeutics, talks about what’s on the horizon for financing and the development of the company's...
January 7, 2019

Notes from the Floor: Biotech Showcase, Day 1

The Biotech Showcase takes place in San Francisco from January 7 to 9. Here's what went on during the conference...
November 19, 2018

Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial

Tenax Therapeutics (Nasdaq:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today...